Transcat (NASDAQ:TRNS) Sets New 1-Year High – Here’s What Happened

Transcat, Inc. (NASDAQ:TRNS)’s share price hit a new 52-week high on Friday . The stock traded as high as $96.60 and last traded at $95.4620, with a volume of 34541 shares traded. The stock had previously closed at $94.54.

More Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s Service segment remains a growth driver, with management targeting high-single-digit organic growth while expanding its operational-excellence initiatives. Transcat targets high single-digit Service organic growth as operational excellence focus expands
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with EPS of $0.51 versus the $0.38 consensus estimate and revenue of $92.95 million compared with expectations of $86.55 million. However, margin pressures remain, particularly despite the Service segment’s growth. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist
• Neutral Sentiment: Northland Securities lowered its rating on TRNS to “Market Perform” and maintained a $95 price target, roughly in line with the stock’s recent trading level. Transcat Rating Lowered to Market Perform at Northland Securities
• Negative Sentiment: Northland cut EPS forecasts across multiple periods: Q3 2027 to $0.20 from $0.38, FY2027 to $1.71 from $1.86, FY2028 to $2.12 from $2.33, FY2029 to $2.58 from $3.18, and FY2030 to $3.01 from $3.51. It also reduced Q2 2027, Q4 2027 and FY2031 estimates. These revisions signal weaker expected earnings momentum and are the main pressure on the shares.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on TRNS. Zacks Research raised Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. Northland Securities downgraded Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price objective for the company. in a research report on Wednesday. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. Finally, Wall Street Zen raised shares of Transcat from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $105.50.

Transcat Price Performance

The company has a current ratio of 2.49, a quick ratio of 1.99 and a debt-to-equity ratio of 0.36. The company’s fifty day moving average is $89.42 and its two-hundred day moving average is $79.52. The stock has a market cap of $884.94 million, a price-to-earnings ratio of 257.72 and a beta of 0.68.

Transcat (NASDAQ:TRNS) last announced its earnings results on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Transcat had a return on equity of 5.56% and a net margin of 0.99%.The company had revenue of $92.95 million for the quarter, compared to analyst estimates of $86.55 million. As a group, research analysts predict that Transcat, Inc. will post 1.63 earnings per share for the current year.

Institutional Investors Weigh In On Transcat

Several institutional investors and hedge funds have recently modified their holdings of the company. Deutsche Bank AG raised its holdings in shares of Transcat by 4.6% in the 4th quarter. Deutsche Bank AG now owns 7,053 shares of the scientific and technical instruments company’s stock valued at $400,000 after purchasing an additional 312 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Transcat by 6.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock worth $407,000 after purchasing an additional 325 shares in the last quarter. Swiss National Bank grew its stake in shares of Transcat by 2.2% during the fourth quarter. Swiss National Bank now owns 18,315 shares of the scientific and technical instruments company’s stock worth $1,039,000 after purchasing an additional 400 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Transcat by 8.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock valued at $299,000 after buying an additional 432 shares during the last quarter. Finally, Diversified Trust Co increased its holdings in Transcat by 8.8% in the first quarter. Diversified Trust Co now owns 5,495 shares of the scientific and technical instruments company’s stock valued at $404,000 after buying an additional 444 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.